Vimarsana
Biggest News Aggregation in the World

Page 3 - Issue Notification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Issue Notification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Issue Notification Today - Breaking & Trending Today

Patents Are Going Paperless | Dunlap Bennett & Ludwig PLLC - Vimarsana News

Patents Are Going Paperless | Dunlap Bennett & Ludwig PLLC

Inventors prize their bound hardcopy patents for both sentimental reasons and because the hardcopy can be useful in negotiation. The USPTO only issues one original “Letters Patent.” If...

USPTO Transitioning to Electronic Patent Grants Starting April 18 | Amundsen Davis LLC - Vimarsana News

USPTO Transitioning to Electronic Patent Grants Starting April 18 | Amundsen Davis LLC

On April 18, 2023 the United States Patent and Trademark Office (USPTO) will start issuing Electronic Patent Grants (eGrants). Under the current paper-laden system and toward th...

USPTO to Transition to Electronic Patent Grants | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

USPTO to Transition to Electronic Patent Grants | McDonnell Boehnen Hulbert & Berghoff LLP

In a final rule published in the Federal Register (88 Fed. Reg. 12560) last week, the U.S. Patent and Trademark Office announced that it will start issuing patents electronically under...

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue - Vimarsana News

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

01.02.2023 - New United States patents will provide further support for the Company’s proprietary position in a key jurisdiction United States grants will bring the Company’s total to 16 granted patents and over 90 applications pending LONDON, Feb. 01, 2023 ... Seite 1

MediciNova Receives Issue Notification for a New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma - Vimarsana News

MediciNova Receives Issue Notification for a New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma

15.09.2022 - LA JOLLA, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has ... Seite 1